Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Crash on Highway 101 Near Bath Street


Car Rolls Over in Solo-Vehicle Accident in Santa Barbara

Santa Barbara, CA (April 8, 2020) – One person was injured in a rollover crash in Santa Barbara. The accident occurred on the evening of April 8 on Highway 101.

A Honda Element rolled over in the northbound lanes of Highway 101, near Bath Street. The vehicle flipped several times before coming to a rest on its roof. The driver of the Honda was hospitalized with moderate injuries.

#Santa Barbara

#93101


May 18, 2020

Pedestrian Killed in Crash on Sierra Avenue

Man Hit by Car in Fatal Fontana Accident ...


October 4, 2019

Man Killed in Crash on Interstate 5 Near Elk Grove Boulevard

Toyota Rear-Ends Semi Truck in Fatal Elk Grove Accident Elk Grove, CA (October ...


October 2, 2019

1 Killed in Crash at Monte Road and Avila Beach Drive

SUV Goes Down Embankment, Hits Tree in Fatal Avila Beach Accident Avila Beach, ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.